ICB PHARMA TOMASZ ŚWIĘTOSŁAWSKI,PAWEŁ ŚWIĘTOSŁAWSKI SPÓŁKA JAWNA
Key data
Status
KRS number
REGON
NIP/VAT code
VAT registration date
VAT status
Bankruptcy proceedings
ICB PHARMA TOMASZ ŚWIĘTOSŁAWSKI,PAWEŁ ŚWIĘTOSŁAWSKI SPÓŁKA JAWNA
Contacts
Registered address
Website
WWW.ICBPHARMA.PL
Not calculatedReliability
Prescore cannot be calculated because the company delayed submission of financial statements.
Incorporation date
10/02/2003Share capital
No dataPrimary activity
Manufacture of other organic basic chemicalsRepresentatives
2Representatives rights
WYMAGANE WSPÓŁDZIAŁANIE DWÓCH WSPÓLNIKÓW ŁĄCZNIERepresentatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
Paweł Świętosławski | Position unknown |
Tomasz Świętosławski | Position unknown |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
21,763,000Net Profit (zł)
21,763,000Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2020 |
|---|
| 88,096,000 |
| 21,763,000 |
| 21,763,000 |
| 0.33 |
| 3.22 |
| 24.70 |
| 50,272,000 |
| 13,162,000 |
| 2,509,000 |
| 24,929,000 |
| 2021 |
|---|
| 88,096,000 |
| 21,763,000 |
| 21,763,000 |
| 0.33 |
| 3.22 |
| 24.70 |
| 50,272,000 |
| 13,162,000 |
| 2,509,000 |
| 24,929,000 |
| 2022 |
|---|
| 88,096,000 |
| 21,763,000 |
| 21,763,000 |
| 0.33 |
| 3.22 |
| 24.70 |
| 50,272,000 |
| 13,162,000 |
| 2,509,000 |
| 24,929,000 |
| 2022 |
|---|
| 88,096,000 |
| 21,763,000 |
| 21,763,000 |
| 0.33 |
| 3.22 |
| 24.70 |
| 50,272,000 |
| 13,162,000 |
| 2,509,000 |
| 24,929,000 |
2022
Turnover (zł)
88,096,000 zł
0 % *
Profit before tax (zł)
21,763,000 zł0 % *
Net Profit (zł)
21,763,000 zł0 % *
Working capital requirement (%)
0.33 0.00 % *
Liquidity ratio
3.22 0.00 % *
Net profitability (%)
24.70 %0.00 % *
Equity (zł)
50,272,000 zł0 % *
Current liabilities (zł)
13,162,000 zł0 % *
Non current liabilities (zł)
2,509,000 zł0 % *
Non-current Assets (zł)
24,929,000 zł0 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
ICB PHARMA TOMASZ ŚWIĘTOSŁAWSKI,PAWEŁ ŚWIĘTOSŁAWSKI SPÓŁKA JAWNA Documents
Date | Description |
|---|---|
26/03/2025 | OD 01.01.2024 DO 31.12.2024 |
25/03/2024 | OD 01.01.2023 DO 31.12.2023 |
31/03/2023 | OD 01.01.2022 DO 31.12.2022 |
22/03/2022 | OD 01.01.2021 DO 31.12.2021 |
19/03/2021 | OD 01.01.2020 DO 31.12.2020 |